Hepatitis C as an epidemiological problem in the polish population

L. Sierpińska
{"title":"Hepatitis C as an epidemiological problem in the polish population","authors":"L. Sierpińska","doi":"10.12775/MBS.2015.017","DOIUrl":null,"url":null,"abstract":"Introduction. Hepatitis C (HC) is an important medical and social problem in Poland and worldwide. The etiologic factor of the disease is the hepatitis C virus (HCV), which is transmitted by blood and blood preparation. Objective. Epidemiological analysis of the prevalence of hepatitis C in the Polish population, based on preliminary results of scientific studies and statistical data. Results. The estimation data show that in Poland the number of new cases increases annually by approximately 3000 patients. The HCV is characterized by a high level of genetic changeability, which contributes to the limited therapeutic possibilities and renders the development of a vaccine impossible. Since1997 in Poland, the number of deaths due to HCV infection has been increasing, and in the nearest years it will increase several times. In Poland, hepatitis C is frequently noted among hospital-acquired infections. These infections are one of the most frequent sources of legal proceedings by patients and their families. Conclusions. Hepatitis C (HC) is an important clinical, epidemiological, economic and social problem in Poland and worldwide. HCV is characterized by a high degree of variation, which contributes to the limited therapeutic possibilities and makes it impossible to develop a vaccine. Infections with HCV are a frequent cause for bringing civil cases to court by previous patients against health care facilities for compensations for health loss related with infection acquired during diagnosing and treatment. Considering the high risk of infection with HCV virus in health facilities non-specific diagnostics should be carried out within wide range.","PeriodicalId":18339,"journal":{"name":"Medical and Biological Sciences","volume":"17 1","pages":"41-46"},"PeriodicalIF":0.0000,"publicationDate":"2015-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical and Biological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12775/MBS.2015.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Introduction. Hepatitis C (HC) is an important medical and social problem in Poland and worldwide. The etiologic factor of the disease is the hepatitis C virus (HCV), which is transmitted by blood and blood preparation. Objective. Epidemiological analysis of the prevalence of hepatitis C in the Polish population, based on preliminary results of scientific studies and statistical data. Results. The estimation data show that in Poland the number of new cases increases annually by approximately 3000 patients. The HCV is characterized by a high level of genetic changeability, which contributes to the limited therapeutic possibilities and renders the development of a vaccine impossible. Since1997 in Poland, the number of deaths due to HCV infection has been increasing, and in the nearest years it will increase several times. In Poland, hepatitis C is frequently noted among hospital-acquired infections. These infections are one of the most frequent sources of legal proceedings by patients and their families. Conclusions. Hepatitis C (HC) is an important clinical, epidemiological, economic and social problem in Poland and worldwide. HCV is characterized by a high degree of variation, which contributes to the limited therapeutic possibilities and makes it impossible to develop a vaccine. Infections with HCV are a frequent cause for bringing civil cases to court by previous patients against health care facilities for compensations for health loss related with infection acquired during diagnosing and treatment. Considering the high risk of infection with HCV virus in health facilities non-specific diagnostics should be carried out within wide range.
丙型肝炎是波兰人口中的一个流行病学问题
介绍。丙型肝炎(HC)是波兰和世界范围内一个重要的医疗和社会问题。该病的病因是丙型肝炎病毒(HCV),通过血液和血液制剂传播。目标。基于科学研究和统计数据的初步结果,对波兰人口中丙型肝炎患病率进行流行病学分析。结果。估计数据显示,在波兰,新病例的数量每年增加约3000名患者。丙型肝炎病毒的特点是高度的遗传变异性,这导致治疗可能性有限,并使疫苗的开发成为不可能。自1997年以来,波兰因丙型肝炎病毒感染而死亡的人数一直在增加,最近几年将增加数倍。在波兰,丙型肝炎在医院获得性感染中很常见。这些感染是患者及其家属提起法律诉讼的最常见来源之一。结论。丙型肝炎(HC)是波兰和世界范围内重要的临床、流行病学、经济和社会问题。丙型肝炎病毒的特点是高度变异,这导致治疗可能性有限,使研制疫苗成为不可能。丙型肝炎病毒感染是以前的患者向法院提起民事诉讼的一个常见原因,要求卫生保健机构赔偿与诊断和治疗期间获得的感染有关的健康损失。考虑到卫生机构感染丙型肝炎病毒的高风险,应在大范围内进行非特异性诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信